Production (Stage)
Endo, Inc.
NDOI
$20.85
-$0.05-0.24%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.73B | 1.76B | 1.79B | 1.82B | 1.92B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.73B | 1.76B | 1.79B | 1.82B | 1.92B |
| Cost of Revenue | 1.39B | 1.38B | 784.68M | 813.37M | 844.50M |
| Gross Profit | 340.46M | 383.65M | 1.01B | 1.00B | 1.07B |
| SG&A Expenses | 559.99M | 541.02M | 543.14M | 533.59M | 547.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.06B | 2.02B | 1.43B | 1.46B | 1.51B |
| Operating Income | -328.00M | -260.11M | 359.76M | 354.38M | 410.60M |
| Income Before Tax | 5.39B | 5.39B | 3.37B | 3.61B | -2.54B |
| Income Tax Expenses | -92.58M | -72.51M | 487.00K | 34.34M | 57.97M |
| Earnings from Continuing Operations | 5.48K | 5.46K | 3.37K | 3.57K | -2.60K |
| Earnings from Discontinued Operations | 183.23M | 182.84M | 182.39M | 181.85M | -1.96M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.67B | 5.64B | 3.55B | 3.75B | -2.60B |
| EBIT | -328.00M | -260.11M | 359.76M | 354.38M | 410.60M |
| EBITDA | 47.11M | 113.06M | 723.72M | 643.92M | 713.70M |
| EPS Basic | 45.49 | 46.52 | 40.73 | 43.66 | -11.06 |
| Normalized Basic EPS | -4.63 | -4.37 | 0.76 | 0.94 | 1.07 |
| EPS Diluted | 45.48 | 46.52 | 40.72 | 43.66 | -11.06 |
| Normalized Diluted EPS | -4.63 | -4.37 | 0.76 | 0.94 | 1.07 |
| Average Basic Shares Outstanding | 344.88M | 503.89M | 662.96M | 822.02M | 940.88M |
| Average Diluted Shares Outstanding | 344.88M | 503.89M | 662.96M | 822.02M | 940.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |